Advanced Therapeutics is a graduate-level program focused on the science and translation of next-generation treatments, including cell and gene therapy (CGT), immunotherapy, and personalized medicine. Students build research and analytical skills through an interdisciplinary curriculum connected to real-world biomedical innovation.
The Advanced Therapeutics program at Drexel University is a graduate-level course designed for those interested in the forefront of biomedical innovation. This 12-month program focuses on the development and translation of next-generation treatments, including cell and gene therapy, immunotherapy, and personalized medicine. Students engage in an interdisciplinary curriculum that fosters research and analytical skills essential for success in the rapidly evolving field of therapeutics.
The curriculum encompasses a variety of core and specialized topics to provide a comprehensive understanding of advanced therapeutic approaches. Students can expect to cover:
For precise details regarding the course structure, including module titles and any capstone or thesis requirements, prospective students should refer to the official program website.
To apply for the Advanced Therapeutics program, candidates must provide official transcripts from all previous institutions. While specific GRE or GMAT scores are not required, applicants should ensure they meet the general academic standards set by the university.
Graduates of the Advanced Therapeutics program will be well-equipped for a variety of career paths in the biomedical sector. Potential roles include positions in research and development, regulatory affairs, clinical trials management, and roles within pharmaceutical or biotechnology companies focused on innovative therapeutic strategies. The skills acquired throughout the program will prepare students to contribute effectively to the advancement of healthcare solutions worldwide.
Shortlist scholarships and plan your application — free guidance from our advisors.